Science Strategic Acquisition Alpha EBIT

Science Strategic Acquisition Alpha posts a EBIT of $1.8B as of September 2022. That compares with $-940K in the prior-year period — up 191560.5% year over year. That is below the sector sector average of $2.6T. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Science Strategic Acquisition Alpha's EBIT was $-940K. The latest reading is $1.8B — a 191560.5% year-over-year increase (period ending September 2022). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a EBIT near $2.6T is typical. Science Strategic Acquisition Alpha's $1.8B is lower that level. That is roughly 99.9% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Science Strategic Acquisition Alpha's financial statement story. At $1.8B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SSAA's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $2.6T), and (3) consistency with growth and profitability. This page covers the first two; Science Strategic Acquisition Alpha's other metric pages and overview cover the third.